MG50.6ICD-11 MMS 2026-01
Antibiotic resistant Neisseria gonorrhoeae
Coding note
These categories should never be used in primary coding. The codes are provided for use as supplementary or additional codes when it is desired to identify the resistance, non-responsiveness and refractive properties of a condition to antimicrobials. In case of multiple resistances, code each one separately if listed below.
Coding note from above levels
These categories should never be used in primary coding. The codes are provided for use as supplementary or additional codes when it is desired to identify the resistance, non-responsiveness and refractive properties of a condition to antimicrobials.
Exclusions from above levels
Child codes
MG50.60– Third generation cephalosporin resistant Neisseria gonorrhoeaeMG50.61– Macrolide resistant Neisseria gonorrhoeaeMG50.62– Aminocyclitol resistant Neisseria gonorrhoeaeMG50.63– Fluoroquinolone resistant Neisseria gonorrhoeaeMG50.64– Aminoglycoside resistant Neisseria gonorrhoeaeMG50.6Y– Neisseria gonorrhoeae resistant to other antibioticMG50.6Z– Neisseria gonorrhoeae resistant to unspecified antibiotic
Sibling codes
MG50.0– Antibiotic resistant Acinetobacter baumanniiMG50.1– Antibiotic resistant CampylobacterMG50.2– Antibiotic resistant Escherichia coliMG50.3– Antibiotic resistant Haemophilus influenzaeMG50.4– Antibiotic resistant Helicobacter pyloriMG50.5– Antibiotic resistant Klebsiella pneumoniaeMG50.7– Antibiotic resistant Neisseria meningitidisMG50.8– Antibiotic resistant Pseudomonas aeruginosaMG50.9– Antibiotic resistant SalmonellaMG50.A– Antibiotic resistant ShigellaMG50.B– Antibiotic resistant VibrioMG50.C– Other antibiotic resistant EnterobacteralesMG50.Y– Other specified finding of gram negative bacteria resistant to antimicrobial drugsMG50.Z– Finding of gram negative bacteria resistant to antimicrobial drugs, unspecified
Foundation entity
Antibiotic resistant Neisseria gonorrhoeae – http://id.who.int/icd/entity/312500700
Part of: MG50: Finding of gram negative bacteria resistant to antimicrobial drugs › 21: Symptoms, signs or clinical findings, not elsewhere classified